Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT07837934
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT07837934
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Singapore
- Registry status
- Recruiting
Technical summary
Registry record NCT07837934. Randomized; quadruple masking; primary purpose prevention. Start 2025-07-24 (actual); primary completion 2027-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes
- Acronym
- Col-DM
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Condition
- Atherosclerosis
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Colchicine 0.5 MG Oral Tablet Once Daily
- Intervention (Drug)
- Placebo
- Lead sponsor
- Tan Tock Seng Hospital
- Collaborator
- Nanyang Technological University
Record details
- Record id
cardio:ct-nct07837934- Content hash
ad88098a9048164fc43211aa59179c1098454d01f6145792e322d12870cf746f